Search - tctmd.com

Displaying 21 - 40 of 129

Sort: Relevancy | Date

Presentation TCT 2024

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Presenter: CHANG HOON KIM

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

Presenter: Sean Pinney

October 28, 2024

Presentation TCT 2024

TCT 669: Impact of Epilepsy on In-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy: A National Inpatient Sample Analysis

Presenter: Anusha Kavarthapu

October 27, 2024

Presentation TCT 2024

TCT 672: High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy Without Improvement in Outcomes Over the Years

Presenter: Mohammad Reza Movahed

October 27, 2024

Presentation TCT 2024

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

Presenter: Stanislav Fanta

October 27, 2024

Presentation TCT 2024

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Presenter: Himaja Dutt Chigurupati

October 27, 2024

Presentation TCT 2024

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Kylie Duckworth

October 27, 2024

Presentation TCT 2024

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

Presenter: Nikhil Rao

October 27, 2024

Presentation TCT 2024

TCT 879: Perioperative and In-Hospital Outcomes of Dilated Cardiomyopathy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large Cross-Sectional Study Using National Inpatient Sample

Presenter: Ankur Singla

October 27, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

Podcast TCTMD Talking Points

The ATTRibute-CM Trial

September 04, 2024

Advertisement

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

TCT 669: Impact of Epilepsy on In-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy: A National Inpatient Sample Analysis

TCT 672: High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy Without Improvement in Outcomes Over the Years

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

TCT 879: Perioperative and In-Hospital Outcomes of Dilated Cardiomyopathy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large Cross-Sectional Study Using National Inpatient Sample

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

The ATTRibute-CM Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content